Skip to main content

Day: January 6, 2026

Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Accepted in China

If approved, lecanemab may become the first and only anti-amyloid treatment in China to offer an at-home injection from the initiation of treatment for this progressive, relentless disease TOKYO and CAMBRIDGE, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the Biologics License Application (BLA) for the subcutaneous formulation (subcutaneous autoinjector: SC-AI) of “LEQEMBI®” (brand name in China: “乐意保®”, generic name: lecanemab), an anti-amyloid beta (Aβ) protofibril antibody, has been accepted by the National Medical Products Administration (NMPA) in China. If approved, the SC-AI of 500 mg (two 250 mg injections) could be used...

Continue reading

HII Hosts Secretary of War Pete Hegseth at Newport News Shipbuilding

NEWPORT NEWS, Va., Jan. 05, 2026 (GLOBE NEWSWIRE) — HII (NYSE: HII) hosted Secretary of War Pete Hegseth at its Newport News Shipbuilding division today. The visit is part of Hegseth’s “Arsenal of Freedom” industry tour. During his visit to the shipyard, Hegseth met with HII and shipyard leadership and spent significant time interacting directly with shipbuilders and sailors. “Our warfighters cannot win without you,” Hegseth told shipbuilders. “We are in this fight together, shoulder to shoulder.” “There is an unbreakable line tying the wrench in your hand to the safety and survival of a 22-year-old American sailor patrolling the depths of the Pacific. The quality of your work, your unwavering commitment to excellence, your speed, your patriotism itself. You give our warrior the decisive edge.”Photos accompanying this release...

Continue reading

ASUS Republic of Gamers Presents Next-Gen Gaming Innovations, Commemorates 20 Years of Gaming Excellence at CES 2026

ROG showcases world-first technologies, next-generation gaming systems, and visionary collaborations that redefine gaming experiences KEY POINTSTwo decades of gaming leadership: At its Dare to Innovate virtual event, ROG celebrates 20 years of fearless experimentation and bold innovation Cross-domain collaborations: ROG and Kojima Productions sign a signature ROG Flow Z13-KJP special edition device and peripherals World’s first dual 16″ screen gaming laptop: ROG raises the bar of innovation to a whole new level with the pioneering Zephyrus Duo LAS VEGAS, Jan. 05, 2026 (GLOBE NEWSWIRE) — ASUS Republic of Gamers (ROG) today announced its Dare to Innovate virtual event at CES 2026, unveiling the next chapter of its vision for gaming performance, design, and culture. The showcase celebrates 20 years of fearless innovation,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.